SCHEMBL23925635

SCHEMBL23925635

CCc1ccc(CC(C)C)c(O)c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.55
GABRB2 P47870 3/20 0.55
ELANE P08246 2/20 0.43
CTSG P08311 1/20 0.43
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
TYR P14679 1/20 0.37
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGS1 P23219 2/20 0.32
PTGS2 P35354 2/20 0.32
LMNA P02545 1/20 0.32
ALB P02768 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23387408 0.90 GABRA1 (0.61) GABRA1GABRB2ELANECTSGALOX15
SCHEMBL6455177 0.82 GABRA1 (0.57) GABRA1GABRB2ELANECTSGTYR
SCHEMBL5587185 0.80 GABRA1 (0.73) GABRA1GABRB2ELANECTSGKDM4E
SCHEMBL7064652 0.78 GABRA1 (0.83) GABRA1GABRB2ELANECTSGALOX15
SCHEMBL29079409 0.78 GABRA1 (0.52) GABRA1GABRB2ELANECTSGALOX15
SCHEMBL28829955 0.75 GABRA1 (0.54) GABRA1GABRB2ELANECTSGALDH1A1
SCHEMBL31620170 0.74 GABRA1 (0.46) GABRA1GABRB2ELANETYRKDM4E
SCHEMBL7623340 0.74 GABRA1 (0.46) GABRA1GABRB2ELANETYRKDM4E
SCHEMBL5678308 0.74 GABRA1 (0.46) GABRA1GABRB2TYRESR1
SCHEMBL6346017 0.72 GABRA1 (0.61) GABRA1GABRB2ELANECTSGALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 GABRA1 1620/4885GABRB2 1511/4885ELANE 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.